eribulin FDA Link

a halichondrin B derivative that suppresses microtubule growth and acts as an antimitotic agent; structure in first source

Also Known As:

2- (3- amino- 2- hydroxypropyl)hexacosahydro- 3- methoxy- 26- methyl- 20,27- bis(methylene)11,15- 18,21- 24,28- triepoxy- 7,9- ethano- 12,15- methano- 9H,15H- furo(3,2- i)furo(2',3'- 5,6)pyrano(4,3- b)(1,4)dioxacyclopentacosin- 5- (4H)- one; B 1793; B 1939; B-1793; B-1939; E 7389; E-7389; ER 086526; ER-086526; ER-86526; ER086526; Halaven; NSC 707389; NSC-707389; NSC707389; eribulin (as mesylate); eribulin mesilate; eribulin mesylate; eribulin monomethanesulfonate

Organic Chemicals: 140
- Ketones: 2712
  - eribulin: 751
- Lactones: 1590
  - Polyketides: 238
    - Polyether Polyketides: 22
      - eribulin: 751
- Ethers: 242
  - Cyclic Ethers: 12
    - Polyether Polyketides: 22
      - eribulin: 751
Polycyclic Compounds: 7
- Macrocyclic Compounds: 16
  - Polyketides: 238
    - Polyether Polyketides: 22
      - eribulin: 751
  - Cyclic Ethers: 12
    - Polyether Polyketides: 22
      - eribulin: 751
Heterocyclic Compounds: 207
- 1-Ring Heterocyclic Compounds
  - Furans: 86
    - eribulin: 751

Madeha Khan Selected Research

Madeha Khan Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure